| Full text | |
| Author(s): |
Rodriguez, Benjamin
[1]
;
Nani, Joao Victor
[1, 2]
;
Almeida, Priscila G. C.
[1]
;
Brietzke, Elisa
[3]
;
Lee, Richard S.
[4]
;
Hayashi, Mirian A. F.
[1, 2]
Total Authors: 6
|
| Affiliation: | [1] Univ Fed Sao Paulo UNIFESP, Dept Farmacol, Escola Paulista Med, Rua 3 Maio 100, Ed INFAR, 3rd Floor, BR-04044020 Sao Paulo, SP - Brazil
[2] Natl Inst Translat Med INCT TM, CNPq FAPESP CAPES, Ribeirao Preto - Brazil
[3] Queens Univ, Dept Psychiat, Sch Med, Kingston, ON - Canada
[4] Johns Hopkins Univ, Dept Psychiat, Baltimore, MD - USA
Total Affiliations: 4
|
| Document type: | Journal article |
| Source: | NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS; v. 108, p. 679-693, JAN 2020. |
| Web of Science Citations: | 0 |
| Abstract | |
Schizophrenia (SCZ) is a complex psychiatric disorder with severe impact on patient's livelihood. In the last years, the importance of neuropeptides in SCZ and other CNS disorders has been recognized, mainly due to their ability to modulate the signaling of classical monoaminergic neurotransmitters as dopamine. In addition, a class of enzymes coined as oligopeptidases are able to cleave several of these neuropeptides, and their potential implication in SCZ was also demonstrated. Interestingly, these enzymes are able to play roles as modulators of neuropeptidergic systems, and they were also implicated in neurogenesis, neurite outgrowth, neuron migration, and therefore, in neurodevelopment and brain formation. Altered activity of oligopeptidases in SCZ was described only more recently, suggesting their possible utility as biomarkers for mental disorders diagnosis or treatment response. We provide here an updated and comprehensive review on neuropeptides and oligopeptidases involved in mental disorders, aiming to attract the attention of physicians to the potential of targeting this system for improving the therapy and for understanding the neurobiology underlying mental disorders as SCZ. (AU) | |
| FAPESP's process: | 14/50867-3 - INCT 2014: National Institute of Science and Technology in Bioanalysis |
| Grantee: | Marco Aurelio Zezzi Arruda |
| Support Opportunities: | Research Projects - Thematic Grants |
| FAPESP's process: | 14/50891-1 - INCT 2014: Translational Medicine |
| Grantee: | Jaime Eduardo Cecilio Hallak |
| Support Opportunities: | Research Projects - Thematic Grants |
| FAPESP's process: | 17/02413-1 - Validation of crotamine as a biomarker and evaluation of its potential use in the therapy of human diseases |
| Grantee: | Mirian Akemi Furuie Hayashi |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 14/18938-8 - Metabolomic profiling of severe mental disorders using Nuclear Magnetic Ressonance (NMR) |
| Grantee: | Ljubica Tasic |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 19/09207-3 - Study of molecular and cellular mechanisms in mental disorders |
| Grantee: | João Victor Silva Nani |
| Support Opportunities: | Scholarships in Brazil - Doctorate |